Anne Devlin
Founder

Education: B.A. Swarthmore College, M.B.A. Columbia University Graduate School of Business where she was elected to Beta Gamma Sigma.

Experience: Anne Devlin’s experience covers a wide range of investment banking transactions include public and private financings, mergers, acquisitions and divestitures, and financial advisory services. Since 1984, her industry focus has been almost exclusively life sciences, medical technology, medical device, biotech and certain healthcare services transactions. Her clients have included Medical Science Partners, Affiliated Healthcare Systems, Lutheran General Health System, Icagen and Kimberly-Clark Corporation. She has also handled transactions for companies in a variety of other industries such as OCLC, a company providing national computerized library services, Magna Software, Heico, Inc. and Syms, Inc.

Noteworthy Positions: Associate, Kuhn Loeb & Co, Inc. (1976 -1977). Vice President, Donaldson Lufkin & Jenrette, Inc. (1977 - 1980), Senior Vice President (1980 - 1983). Vice President and Co-Manager of Healthcare Investment Banking at Chase Manhattan Capital Markets Corporation (1984 - 1989). Managing Director and Co-Head of Healthcare, Bentley Associates (1990 - 2003). Partner, McFarland Dewey & Co. (2003 - 2004).

Email:

Phone: (212) 534-3934

Return to Top

Thomas E. Dewey, Jr.
Founder

Education: B.A. Princeton University, M.B.A. Harvard University

Experience: Tom Dewey’s experience covers all aspects of corporate and public finance, including serving as investment banker to such healthcare companies as Penwest Pharmaceuticals, Epicept, InPhyNet Medical Management and Celsis, Inc. He has specialized experience in mergers and acquisitions divestitures and corporate reorganizations and restructurings. Tom Dewey has testified extensively as an expert in litigation involving financial matters and in regulatory proceedings.

Noteworthy Positions: Associate, Kuhn, Loeb & Co. (1958 –1964), General Partner (1965-1975). President, Thomas E. Dewey Jr. & Co., Inc. (1976 - 989). Founding Partner, (later Member) of McFarland Dewey & Co. (1989 - 2004). Vice Chairman (1972 - 1989) New York City Housing Development Corporation. Former Director Apple Bankcorp, Apple Bank for Savings, Levin-Townsend Computers Corp, Douglas Elliman & Co., GULL, Inc., InPhyNet Medical Management, Inc., Vysis, Inc., and Genelabs Technologies, Inc. Mr. Dewey is a Director of Goldfield Corp, a Retired Director of Northwest National Gas Company, a Trustee of the Scripps Research Institute and an active Trustee (45 years) and Chairman Emeritus of Lenox Hill Hospital. He is also Managing Trustee of the Thomas E. Dewey Fund, a charitable foundation.

Email:

Phone: (212) 867-1182

Return to Top

Rochelle B. King
Founder

Education: B.A. Queens College, CUNY, where she was elected to Phi Beta Kappa, J.D. University of Pennsylvania Law School

Experience: Rochelle King’s experience covers a broad range of investment banking transactions with an emphasis on healthcare/life sciences, media, telecommunications and the food services industries. Her healthcare clients have included Hybritech Partners, L.P. and ML Imaging Partners. She served as a Director of Paging Partners Corporation, and as General Partner of Kagan Media Partners, L.P., a Paine Webber public media partnership. Other clients have included Rocky Mountain Radio, Burke & Burke and ML Media Partners, L.P.

Noteworthy Positions: Associate, Simpson, Thatcher and Bartlett, general corporate and securities law (1977 - 1980). Associate, Phillips, Nizer, Krim and Ballon, general corporate and securities law, (1980 - 1983). Vice President, Merrill Lynch Investment Banking (1983- 1989). President, King Investment Banking, Inc. focusing on media and food services transactions 1989-1991. Managing Director and Co-Head of Healthcare, Bentley Associates (1991 - 2003). Partner, McFarland Dewey & Co.(2003 - 2004).

She serves as an advisor to the David & Gisela King Foundation, which focuses on disadvantaged children, and to Medical Mission International which is building a surgical hospital in El Salvador and providing other medical and educational services.

Email:

Phone: (212) 867-1180

Return to Top

Helen Maslocka
Venture Partner

Helen Maslocka recently joined Dewey Devlin & King as a Venture Partner. She adds a unique perspective which broadens DDK’s ability to advise our clients in the best possible way. Her 25-year career has been spent as an executive in the emerging healthcare information technology, biotech and medial device companies.

Like other DDK partners, she is well known in the healthcare, private equity and venture capital world, but as a senior executive rather than investment banker. Ms. Maslocka is considered an astute business strategist, team builder and skilled at resolving difficult problems effectively as well as experienced in financing and corporate merger and acquisition transactions.

She has successfully implemented corporate partnering, product launch and exit strategies; has raised over $63 million in capital and has successfully positioned companies for two initial public offerings resulting in over $100 million in new capital.

In the area of M&A, Ms. Maslocka has held senior corporate development positions at Leukocyte and Seragon. She was CEO of Greenpages Data Services (Now Medcontrax, Inc.) a B2B ASP software company sold with several multiple returns to investors.

Ms. Maslocka most recently served as President and CEO of CardioFocus, Inc., a disposable photonics-based medical device company where she restructured and refocused the company as a cardiovascular firm and completed a $12 million venture round of financing.

Earlier in her career, Ms. Maslocka led the first international launch of the Lasik procedure for Summit Technology and oversaw business development and capital formation; corporate communications and investor relation activities. She is credited with executing the first PIPE in the biotechnology industry without the benefit of an outside investment banker.

Ms. Maslocka began her career in healthcare services. She held senior positions at Massachusetts General Hospital and Harvard Community Health Plan. This affords her unique insight into how hospitals evaluate new products and has helped her to develop successful sales and marketing programs.

Ms. Maslocka holds a BA from Boston College and a Graduate Certificate in Management from Radcliffe College.

Email: 

Phone: (617) 512-4530

Return to Top

John Metz
Member

From November of 2002 Mr. Metz has served as President of Nauset Biomedical Partners, a consulting firm for early-stage medical and biotechnology companies. In 2006 he served as interim President and COO of Safe Life Corp a San Diego company founded in 2006 to acquire the assets of Triosyn Corp. Triosyn is a Montreal based technology firm with unique antimicrobial technology with specific focus in avian flu protection and healthcare environment acquired infections. Mr. Metz was part of the management team led by Richard Jaffe, Chairman and CEO of Safe Life and former Chairman and CEO of SAFESKIN Corporation, that acquired Triosyn and took over its management and operations. The investment group was led by Vantage Pont Venture Partners, San Bruno, CA and Mr. Jaffe.

Mr. Metz served as President and CEO of Bio-Plexus, Inc (NASDAQ Small Cap) from 2000 through 2002. The company’s products were safety blood collection needles and catheters for labs and ICUs. The company was successfully sold to ICU Medical (NASDAQ) of San Clemente, CA.

From 1982 through 2000, he served in a variety of capacities with increasing responsibility at Kimberly-Clark Corporation, one of the leading global health and hygiene companies. Mr. Metz became President of the Professional Healthcare Sector in 1991 and co-president as President for Strategic Acquisitions in 1997. During Mr. Metz tenure the Sector grew from $75 million in revenue to $1 billion in 2000. As head of strategy and acquisitions the business was tripled in size from 1997 to 2000 with the acquisitions of Tecnol Medical Products Corp, Ballard Medical and SAFESKIN all NASDAQ companies.

Additionally, during the period 1997-2000 Mr. Metz initiated and led Kimberly-Clark Ventures LLC for strategic investment in early-stage medical device companies.

Prior to joining Kimberly-Clark, Mr. Metz held marketing positions with Becton-Dickinson and Company (1976-1982), McKesson Corporation (1974-1976) and The Coca-Cola Company (1970-1974).

Mr. Metz was a First Lieutenant in the U.S. Army. He holds both Bachelor's and Master's degrees in mathematics from the University of Mississippi and an MBA from Stanford University in finance and marketing. As an undergraduate he was a scholar athlete.

He is a past member of the Board of Trustees for the National Foundation for Infectious Diseases and past member of the Board of Advisors for the Georgetown University School of Nursing. He is a student career advisor for the Georgia State University – J. Mack Robinson College of Business.

Email: 

Phone: (508) 246-1987

Return to Top